These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7698017)

  • 1. FISH analyses of a newly established thyroid tumor cell line showing a t(1;19)(p35 or p36.1;q13) reveal that the breakpoint lies between 19q13.3-13.4 and 19q13.4.
    Belge G; Garcia E; de Jong P; Bartnitzke S; Bullerdiek J
    Cytogenet Cell Genet; 1995; 69(3-4):220-2. PubMed ID: 7698017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakpoints of 19q13 translocations of benign thyroid tumors map within a 400 kilobase region.
    Belge G; Garcia E; Rippe V; Fusco A; Bartnitzke S; Bullerdiek J
    Genes Chromosomes Cancer; 1997 Oct; 20(2):201-3. PubMed ID: 9331571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations.
    Belge G; Rippe V; Meiboom M; Drieschner N; Garcia E; Bullerdiek J
    Cytogenet Cell Genet; 2001; 93(1-2):48-51. PubMed ID: 11474178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrations of chromosome 19. Do they characterize a subtype of benign thyroid adenomas?
    Belge G; Thode B; Bullerdiek J; Bartnitzke S
    Cancer Genet Cytogenet; 1992 May; 60(1):23-6. PubMed ID: 1591702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A KRAB zinc finger protein gene is the potential target of 19q13 translocation in benign thyroid tumors.
    Rippe V; Belge G; Meiboom M; Kazmierczak B; Fusco A; Bullerdiek J
    Genes Chromosomes Cancer; 1999 Nov; 26(3):229-36. PubMed ID: 10502321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of 19q13 in follicular thyroid adenoma.
    Dal Cin P; Sneyers W; Aly MS; Segers A; Ostijn F; Van Damme B; Van Den Berghe H
    Cancer Genet Cytogenet; 1992 May; 60(1):99-101. PubMed ID: 1591716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular definition of chromosome translocations involving 10q24 and 19q13 in human malignant glioma cells.
    Chernova O; Cowell JK
    Cancer Genet Cytogenet; 1998 Aug; 105(1):60-8. PubMed ID: 9689932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
    Laureys GG
    Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does conventional cytogenetics detect the real frequency of 19q13 aberrations in benign thyroid lesions? A survey of 38 cases.
    Meiboom M; Belge G; Bol S; El-Aouni C; Schoenmakers EF; Bullerdiek J
    Cancer Genet Cytogenet; 2003 Oct; 146(1):70-2. PubMed ID: 14499699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis.
    Lestou VS; Ludkovski O; Connors JM; Gascoyne RD; Lam WL; Horsman DE
    Genes Chromosomes Cancer; 2003 Apr; 36(4):375-81. PubMed ID: 12619161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recurrent 19q11-12 breakpoint suggested by cytogenetic and fluorescence in situ hybridization analysis of three glioblastoma cell lines.
    Magnani I; Chiariello E; Conti AM; Finocchiaro G
    Cancer Genet Cytogenet; 1999 Apr; 110(2):82-6. PubMed ID: 10214354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas.
    Rippe V; Dittberner L; Lorenz VN; Drieschner N; Nimzyk R; Sendt W; Junker K; Belge G; Bullerdiek J
    PLoS One; 2010 Mar; 5(3):e9485. PubMed ID: 20209130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers.
    Laureys G; Speleman F; Versteeg R; van der Drift P; Chan A; Leroy J; Francke U; Opdenakker G; Van Roy N
    Oncogene; 1995 Mar; 10(6):1087-93. PubMed ID: 7700633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the chromosome 12 translocation breakpoint region of a pleomorphic salivary gland adenoma with t(1;12)(p22;q15) as the sole cytogenetic abnormality.
    Kools PF; Wanschura S; Schoenmakers EF; Geurts JM; Mols R; Kazmierczak B; Bullerdiek J; Van den Berghe H; Van de Ven WJ
    Cancer Genet Cytogenet; 1995 Jan; 79(1):1-7. PubMed ID: 7850744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma.
    Dave BJ; Hess MM; Pickering DL; Zaleski DH; Pfeifer AL; Weisenburger DD; Armitage JO; Sanger WG
    Clin Cancer Res; 1999 Jun; 5(6):1401-9. PubMed ID: 10389925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic and molecular analysis of a t(1;22)(p36;q11.2) in a rhabdoid tumor with a putative homozygous deletion of chromosome 22.
    Rosty C; Peter M; Zucman J; Validire P; Delattre O; Aurias A
    Genes Chromosomes Cancer; 1998 Feb; 21(2):82-9. PubMed ID: 9491318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics.
    Drieschner N; Rippe V; Laabs A; Dittberner L; Nimzyk R; Junker K; Rommel B; Kiefer Y; Belge G; Bullerdiek J; Sendt W
    Cancer Genet; 2011 Jul; 204(7):366-74. PubMed ID: 21872823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation t(5;19): a recurrent change in thyroid follicular adenoma.
    Roque L; Castedo S; Clode A; Soares J
    Genes Chromosomes Cancer; 1992 Jun; 4(4):346-7. PubMed ID: 1377944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization.
    Chen X; Knauf JA; Gonsky R; Wang M; Lai EH; Chissoe S; Fagin JA; Korenberg JR
    Am J Hum Genet; 1998 Aug; 63(2):625-37. PubMed ID: 9683604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin.
    Drieschner N; Belge G; Rippe V; Meiboom M; Loeschke S; Bullerdiek J
    Thyroid; 2006 Nov; 16(11):1091-6. PubMed ID: 17123335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.